NCT00176930 arm group e3cd5ce4bef2385b6de6a55e0f945390 [clinicaltrials_resource:NCT00176930/arm-group/e3cd5ce4bef2385b6de6a55e0f945390]
Busulfan [clinicaltrials_resource:7829490c96be9552c3d98abcd0ee7dc2]Cyclophosphamide [clinicaltrials_resource:8457e18e1c69aa47712ec0a02ae8cef7]Total Body Irradiation [clinicaltrials_resource:991ce94d874767b4c9741ff8ebdc9460]Stem Cell Transplant [clinicaltrials_resource:eb900ae4e72db477f2341c6ec1c7037d]clinicaltrials:NCT00176930
arm group [clinicaltrials_vocabulary:arm-group]
NCT00176930 arm group e3cd5ce4bef2385b6de6a55e0f945390 [clinicaltrials_resource:NCT00176930/arm-group/e3cd5ce4bef2385b6de6a55e0f945390]
Bio2RDF identifier
NCT00176930/arm-group/e3cd5ce4bef2385b6de6a55e0f945390
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... cd5ce4bef2385b6de6a55e0f945390
description [clinicaltrials_vocabulary:description]
Patients receiving cyclophosph ...... mide, Busulfan and transplant.
identifier
clinicaltrials_resource:NCT00176930/arm-group/e3cd5ce4bef2385b6de6a55e0f945390
title
NCT00176930 arm group e3cd5ce4bef2385b6de6a55e0f945390
@en
type
label
NCT00176930 arm group e3cd5ce4 ...... d5ce4bef2385b6de6a55e0f945390]
@en